Pol Andrés‐Benito

1.9k total citations
62 papers, 1.2k citations indexed

About

Pol Andrés‐Benito is a scholar working on Molecular Biology, Physiology and Neurology. According to data from OpenAlex, Pol Andrés‐Benito has authored 62 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 29 papers in Physiology and 27 papers in Neurology. Recurrent topics in Pol Andrés‐Benito's work include Alzheimer's disease research and treatments (28 papers), Amyotrophic Lateral Sclerosis Research (20 papers) and Parkinson's Disease Mechanisms and Treatments (12 papers). Pol Andrés‐Benito is often cited by papers focused on Alzheimer's disease research and treatments (28 papers), Amyotrophic Lateral Sclerosis Research (20 papers) and Parkinson's Disease Mechanisms and Treatments (12 papers). Pol Andrés‐Benito collaborates with scholars based in Spain, United States and Austria. Pol Andrés‐Benito's co-authors include Isidró Ferrer, Ester Aso, Margarita Carmona, Mónica Povedano, José Antonio del Rı́o, Benjamı́n Torrejón-Escribano, Enrique Santamaría, Joaquín Fernández‐Irigoyen, Paula Garcia‐Esparcia and Raúl Domínguez and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Pol Andrés‐Benito

60 papers receiving 1.2k citations

Peers

Countries citing papers authored by Pol Andrés‐Benito

Since Specialization

Citations

This map shows the geographic impact of Pol Andrés‐Benito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pol Andrés‐Benito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pol Andrés‐Benito more than expected).

Fields of papers citing papers by Pol Andrés‐Benito

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pol Andrés‐Benito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pol Andrés‐Benito. The network helps show where Pol Andrés‐Benito may publish in the future.

Co-authorship network of co-authors of Pol Andrés‐Benito

This figure shows the co-authorship network connecting the top 25 collaborators of Pol Andrés‐Benito. A scholar is included among the top collaborators of Pol Andrés‐Benito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pol Andrés‐Benito. Pol Andrés‐Benito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Microbial Influences on Amyotrophic Lateral Sclerosis: The Gut–Brain Axis and Therapeutic Potential of Microbiota Modulation	SHILAP Revista de lepidopterología	Victòria Ayala, Mónica Povedano et al.	3
2	Nuclear pore complex dysfunction drives TDP-43 pathology in ALS	Redox Biology	Omar Ramírez‐Núñez, Pascual Torres et al.	0
3	Blocking IL-6 signaling prevents astrocyte-induced neurodegeneration in an iPSC-based model of Parkinson’s disease	JCI Insight	Meritxell Pons‐Espinal, Irene Fernández‐Carasa et al.	21
4	Neurodegeneration Biomarkers in Adult Spinal Muscular Atrophy (SMA) Patients Treated with Nusinersen	International Journal of Molecular Sciences	Pol Andrés‐Benito, Juan F. Vázquez‐Costa et al.	7
5	GPR37 processing in neurodegeneration: a potential marker for Parkinson’s Disease progression rate	npj Parkinson s Disease	Marc López‐Cano, Víctor Fernández‐Dueñas et al.	4
6	miR-519a-3p, found to regulate cellular prion protein during Alzheimer's disease pathogenesis, as a biomarker of asymptomatic stages	Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease	Tiziana Cotrufo, Pol Andrés‐Benito et al.	1
7	Primary Feline Tauopathy: Clinical, Morphological, Immunohistochemical, and Genetic Studies	Animals	Gabriel Santpere, Pol Andrés‐Benito et al.	1
8	Deregulated Transcription and Proteostasis in Adult mapt Knockout Mouse	International Journal of Molecular Sciences	Pol Andrés‐Benito, África Flores et al.	2
9	Glycogen accumulation modulates life span in a mouse model of amyotrophic lateral sclerosis	Journal of Neurochemistry	M. Kathryn Brewer, Pascual Torres et al.	6
10	A motor neuron disease mouse model reveals a non-canonical profile of senescence biomarkers	Disease Models & Mechanisms	Pascual Torres, Carlos Anerillas et al.	12
11	Transcriptional signatures of synaptic vesicle genes define myotonic dystrophy type I neurodegeneration	Neuropathology and Applied Neurobiology	Ibai Díez, Andone Sistiaga et al.	12
12	Dysregulated Protein Phosphorylation as Main Contributor of Granulovacuolar Degeneration at the First Stages of Neurofibrillary Tangles Pathology	Neuroscience	Pol Andrés‐Benito, Margarita Carmona et al.	13
13	Lipid alterations in human frontal cortex in ALS‐FTLD‐TDP43 proteinopathy spectrum are partly related to peroxisome impairment	Neuropathology and Applied Neurobiology	Pol Andrés‐Benito, Ellen Gelpí et al.	15
14	The Presence of Human Herpesvirus 6 in the Brain in Health and Disease	Biomolecules	Gabriel Santpere, Pol Andrés‐Benito et al.	34
15	Motor neuron preservation and decrease of in vivo TDP-43 phosphorylation by protein CK-1δ kinase inhibitor treatment	Scientific Reports	Loreto Martínez‐González, Carmen Rodríguez‐Cueto et al.	42
16	Cannabidiol-Enriched Extract Reduced the Cognitive Impairment but Not the Epileptic Seizures in a Lafora Disease Animal Model	Cannabis and Cannabinoid Research	Ester Aso, Pol Andrés‐Benito et al.	11
17	Wnt Signaling Alterations in the Human Spinal Cord of Amyotrophic Lateral Sclerosis Cases: Spotlight on Fz2 and Wnt5a	Molecular Neurobiology	Carlos González‐Fernández, Pau González et al.	29
18	PPARγ agonist-loaded PLGA-PEG nanocarriers as a potential treatment for Alzheimer’s disease: in vitro and in vivo studies	International Journal of Nanomedicine	Marcelle Silva-Abreu, Ana Cristina Calpena et al.	64
19	MicroRNA Expression in the Locus Coeruleus, Entorhinal Cortex, and Hippocampus at Early and Middle Stages of Braak Neurofibrillary Tangle Pathology	Journal of Molecular Neuroscience	Franc Llorens, Katrin Thüne et al.	17
20	Amyloid and tau pathology of familial Alzheimer’s disease APP/PS1 mouse model in a senescence phenotype background (SAMP8)	AGE	David Porquet, Pol Andrés‐Benito et al.	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact